Cough Kids: Soothing Throat Spray for Children’s Cough Relief

Understanding Cough in Children

What is Cough in Children?

Coughing is a common reflex action in children that clears the throat and lungs of irritants, mucus, or foreign particles. While it’s a normal part of childhood illness, persistent coughing can sometimes indicate an underlying medical condition that requires attention.

Causes of Cough in Children

Cough in children can be caused by a variety of factors. These include common conditions such as colds and flu, allergies, asthma, and exposure to environmental irritants. In some cases, coughing can also be a symptom of more serious conditions such as pneumonia or cystic fibrosis.

Impact of Cough on Children’s Health

Persistent coughing can have a significant impact on a child’s health and quality of life. It can disrupt sleep, cause fatigue, and in severe cases, lead to complications such as difficulty breathing or chest pain. Chronic cough can also be distressing for both the child and their parents, leading to anxiety and stress.

Treatment of Cough in Children

The treatment of cough in children depends on the underlying cause. For coughs caused by colds and flu, rest and hydration are often the best remedies. Over-the-counter cough medicines can sometimes be used in older children, but are not recommended for children under the age of six. For chronic conditions such as asthma, long-term medication may be needed. In all cases, it’s important to seek medical advice if a child’s cough is persistent, severe, or accompanied by other worrying symptoms

CLAIMS IN LINE WITH THE NEW REGULATION

Reduces coughing in children
Reduces throat irritation
Improves quality of life
Improves sleep
Non-addictive
Non-drowsy

CLINICAL TRIAL

General data

• Title: Clinical Efficacy and Safety of the 1st Non-Medicated, Safe, and Nearly Instant Cough Treatment for Children
• Publication Date: 2023
• Objective: The study aimed to evaluate the efficacy and safety of a new non-medicated cough treatment for children. This treatment involves a topical polymeric film that cleans the throat surface and fluidizes mucus. The study compared the efficacy of this treatment to a saline solution.
• Methodology: The study was conducted on 30 children aged between 3 to 15 years. The children were divided into two groups: one group received the topical polymeric treatment (TP group), and the other group received a saline solution (CP group). The primary endpoint was the change in cough frequency score on a 0 (no symptom) to 10 (worst symptom) scoring scale, at 2 hours after the start of treatment (1st application) on day 1, on day 3, day 6, and day 15, or up to complete recovery compared to placebo. Secondary endpoints included changes in chest discomfort, throat irritation, and fever at 2 hours after the 1st application on day 1 as well as on day 3, day 6, and day 15 or up to complete recovery.

Results :

After 3 days of treatment, the group treated with the topical polymeric film COUGHKIDS (TP group) experienced a 45.79% reduction in cough frequency, compared to the baseline.

By day 6, the reduction in cough frequency in the TP group increased to 89.71%, and by day 15, it reached 98.13%.

Sleep disturbances due to night coughing were significantly reduced in the TP group, with a 55.56% reduction observed by day 3, 75.76% by day 6, and 97.98% by day 15.

Throat irritation was also significantly reduced in the TP group, with a 66% reduction observed by day 3, 88% by day 6, and 98% by day 15.

The Quality of Life (QOL) score improved significantly in the TP group after 14 days of treatment, reaching a mean score of 41.60/70, compared to 23.30/70 in the control group (CP group).

These results suggest that the topical polymeric treatment was significantly more effective than the saline solution in reducing cough frequency, cough-induced sleep disturbance, and throat irritation, and in improving the quality of life.

Conclusion

In conclusion, COUGHKIDS has shown promising results in clinical trials. The treatment was found to significantly suppress cough symptoms within just three days of application, reducing the need for antibiotics.

This is particularly noteworthy given the growing concern about antibiotic resistance and the side effects of chemical cough treatments. The fact that no adverse effects were reported during the trial further underscores the safety of this treatment.

Overall, this innovative approach to treating cough in children could potentially offer a safe, effective, and non-chemical alternative to traditional cough treatments, providing a new option for parents and healthcare providers in managing this common childhood ailment.